Home » Topics » BioWorld Science

BioWorld Science
RSS

Thalidomide clinical trials in brain cancer expanded

Nov. 21, 1996

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

Nov. 21, 1996

NIH to conduct clinical trial of Ampalex in AD

Nov. 21, 1996

Pharmagenesis and Lilly collaborate on development of antifungal agents

Nov. 21, 1996

IVAX and Glaxo Wellcome to expand Easi-Breathe agreement

Nov. 21, 1996

Angiogenesis-inhibitory activity reported for spironolactone

Nov. 21, 1996

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Nov. 21, 1996

Solvay and TheraTech end HRT collaboration

Nov. 21, 1996

Arris/Merck & Co. osteoporosis collaboration

Nov. 21, 1996

French market introduction for Fractal

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...